afdx 116 has been researched along with hemicholinium 3 in 1 studies
| Studies (afdx 116) | Trials (afdx 116) | Recent Studies (post-2010) (afdx 116) | Studies (hemicholinium 3) | Trials (hemicholinium 3) | Recent Studies (post-2010) (hemicholinium 3) |
|---|---|---|---|---|---|
| 367 | 1 | 24 | 963 | 1 | 34 |
| Protein | Taxonomy | afdx 116 (IC50) | hemicholinium 3 (IC50) |
|---|---|---|---|
| Vesicular acetylcholine transporter | Homo sapiens (human) | 0.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sapru, H; Sundaram, K | 1 |
1 other study(ies) available for afdx 116 and hemicholinium 3
| Article | Year |
|---|---|
Cholinergic nerve terminals in the ventrolateral medullary pressor area: pharmacological evidence.
Topics: 4-Aminopyridine; Acetylcholine; Amifampridine; Aminopyridines; Animals; Blood Pressure; Hemicholinium 3; Medulla Oblongata; Microinjections; Nerve Endings; Parasympathetic Nervous System; Pirenzepine; Receptors, Muscarinic; Scopolamine; Sympathetic Nervous System | 1988 |